Immunome
IMNM
IMNM
35 hedge funds and large institutions have $19.7M invested in Immunome in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
40% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 10
Holders
35
Holding in Top 10
–
Calls
$474K
Puts
$304K
Top Buyers
| 1 | +$1.45M | |
| 2 | +$1.07M | |
| 3 | +$1.06M | |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$449K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$414K |
Top Sellers
| 1 | -$531K | |
| 2 | -$308K | |
| 3 | -$171K | |
| 4 |
HBCM
Heron Bay Capital Management
Bloomfield Hills,
Michigan
|
-$104K |
| 5 |
Renaissance Technologies
New York
|
-$101K |